Life & Science News & Job Source
New rules on generics seen as mixed blessing
A small piece of the new health care law provides a way for drug manufacturers to eventually create generic versions of brand-name biologic drugs. But some say the provision that allows biotechnology companies to hold on to their data exclusively for 12 years… Health care – Biologic – Drug Manufacturers – Major – United States – Law
Read more on San Francisco Chronicle
Drug lobby’s health care win
WASHINGTON (AP) — Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama’s health care law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain health coverage.
Read more on KIMT Mason City
THE INFLUENCE GAME: Drug lobby’s health care win
Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama’s health care law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain health coverage.
Read more on Boston Globe
Humira Replaces Enbrel as the Therapy Perceived by Dermatologists to be the Most Efficacious for the Treatment of …
WALTHAM, Mass., March 23 /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai’s Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis.
Read more on redOrbit
Drug ETFs Likely Winners of Health Law
Exchange-traded funds with drugmakers as holdings likely will reap benefits from the passage of U.S. health care reform.
Read more on TheStreet.com
Product DescriptionGet the … [Read More...]
Product DescriptionThoroughly … [Read More...]
Copyright © 2012 · Enterprise Theme on Genesis Framework · WordPress · Log in